Original Article Prognostic significance of reduced immunohistochemical expression of E-cadherin in endometrial cancer-results of a meta-analysis
作者： Xing Zheng , Tao Jiang , Xue-Lian Du
DOI:
关键词:
摘要: Objective: Previous studies which investigated the relationship between reduced E-cadherin and progno- sis of endometrial cancer were ambiguous conflicting. Therefore, aim present study was to evaluate expression by meta-analysis approach. Method: AfterPubmed Embasewere deliberately searched via internet, 8 pieces literaturewere totally included in final meta-analysis. After data had been abstracted, pulled odds ratio (OR) hazard (HR) calculated STATA with random or fixed effect model depending on their heterogeneity. The publication bias literature tested Begg's funnel plot Egger's test. Results: showed that re- duced significantly associated overall survival (OS), HR=2.42, 95% CI: 1.50-3.89. clinical parameters such as lymph node metastasis (LNM), myometrial invasion (MI), International Federation Gynecology Obstetrics (FIGO) stage, histological type pathological also E-cadherin. results biasshowed there no significant bias. Conclusion: Endometrial patients may have a poorer prognosis than those normal higher
ijcem.com 参考文章(28)
Meral Koyuncuoglu, Emre Okyay, Bahadir Saatli, Safak Olgan, Mustafa Akin, Ugur Saygili, Tumor budding and E-Cadherin expression in endometrial carcinoma: Are they prognostic factors in endometrial cancer? Gynecologic Oncology. ,vol. 125, pp. 208- 213 ,(2012) , 10.1016/J.YGYNO.2011.12.433
Shan-Yun Wen, Li-Na Zhang, Xiao-Mei Yang, Yan-Li Zhang, Li Ma, Qiu-Lin Ge, Shu-Heng Jiang, Xiao-Lu Zhu, Wei Xu, Wen-Jing Ding, Bing-Qing Yang, Zhi-Gang Zhang, Yin-Cheng Teng, LRG1 is an independent prognostic factor for endometrial carcinoma Tumor Biology. ,vol. 35, pp. 7125- 7133 ,(2014) , 10.1007/S13277-014-1953-6
Jayne F Tierney, Lesley A Stewart, Davina Ghersi, Sarah Burdett, Matthew R Sydes, Practical methods for incorporating summary time-to-event data into meta-analysis Trials. ,vol. 8, pp. 16- 16 ,(2007) , 10.1186/1745-6215-8-16
Jaime Prat, Prognostic parameters of endometrial carcinoma. Human Pathology. ,vol. 35, pp. 649- 662 ,(2004) , 10.1016/J.HUMPATH.2004.02.007
Wiljo J. F. de Leeuw, Geert Berx, Carla B. J. Vos, Johannes L. Peterse, Marc J. Van de Vijver, Sergey Litvinov, Frans Van Roy, Cees J. Cornelisse, Anne-marie Cleton-Jansen, Simultaneous loss of E-cadherin and catenins in invasive lobular breast cancer and lobular carcinoma in situ. The Journal of Pathology. ,vol. 183, pp. 404- 411 ,(1997) , 10.1002/(SICI)1096-9896(199712)183:4<404::AID-PATH1148>3.0.CO;2-9
Irina V. Kovtun, Kimberly J. Harris, Aminah Jatoi, Dragan Jevremovic, Increased incidence of endometrioid tumors caused by aberrations in E-cadherin promoter of mismatch repair-deficient mice. Carcinogenesis. ,vol. 32, pp. 1085- 1092 ,(2011) , 10.1093/CARCIN/BGR080
XL Xu, Z Q Ling, SZ Chen, B Li, WH Ji, WM Mao, None, The impact of E-cadherin expression on the prognosis of esophageal cancer: a meta-analysis Diseases of the Esophagus. ,vol. 27, pp. 79- 86 ,(2014) , 10.1111/DOTE.12024
Loren K. Mell, Jeffrey J. Meyer, Maria Tretiakova, Andrey Khramtsov, Can Gong, S. Diane Yamada, Anthony G. Montag, Arno J. Mundt, Prognostic Significance of E-Cadherin Protein Expression in Pathological Stage I-III Endometrial Cancer Clinical Cancer Research. ,vol. 10, pp. 5546- 5553 ,(2004) , 10.1158/1078-0432.CCR-0943-03
Tie-Zhong Yi, Jing Guo, Lili Zhou, Xing Chen, Ruo-Ran Mi, Quan-Xin Qu, Jian-Hua Zheng, Ling Zhai, Prognostic Value of E-Cadherin Expression and CDH1 Promoter Methylation in Patients With Endometrial Carcinoma Cancer Investigation. ,vol. 29, pp. 86- 92 ,(2011) , 10.3109/07357907.2010.512603
A. Jemal, R. Siegel, J. Xu, E. Ward, Cancer statistics, 2010 CA: A Cancer Journal for Clinicians. ,vol. 60, pp. 277- 300 ,(2010) , 10.3322/CAAC.20073